On January 22, 2024, MitoSense reached an exciting milestone in its fight to treat neurodegenereagtive diseases with the ribbon cutting of the Carroll A. Campbell, Jr. Alzheimer's Initiative in Greenwood, SC.
The Initiative is being launched at the Greenwood Genetic Center (GCC). Research here will utilize MitoSense's Mitochondria Organelle Transplantation (MOT™) technology in the treatment of Alzheimer's Disease.
South Carolina Governor Henry McMaster headed the ribbon cutting ceremony and remarked that the Initiative "is an academic goldmine."
“The launch of this Alzheimer’s initiative marks a significant milestone in our journey towards understanding and combating neurodegenerative diseases,” said Van Hipp, Chairman of MitoSense. “This ribbon-cutting made possible through generous state funding, is not just about opening doors to a new facility; it’s about unlocking the potential of groundbreaking research and turning it into actionable solutions.”
The Carroll A. Campbell, Jr. Alzheimer’s Initiative is a result of collaboration between GGC, MitoSense, and the U.S. Department of Veterans Affairs. It is backed by $2 million in funding from the South Carolina state budget.
For the full story, check out coverage from WIS News 10 below.
Full remarks made at the event can be viewed at WSPA 7.